Diabetes drugs from Eli Lilly and Novo Nordisk, such as Mounjaro, Zepbound, Ozempic, and Wegovy, are expanding beyond ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...

* Researchers at the Danish Headache Center are testing semaglutide along with a very low calorie diet as a treatment for new ...

Liver cancer is still relatively rare in the United States, representing 2.1% of all new cancer diagnoses in 2025. The report ...

CVS acknowledged that Zepbound has been shown to help people lose more weight than Wegovy, but that Wegovy can still help ...

Sally Love has always enjoyed a drink - but, like many, it was during the Covid pandemic that her alcohol intake began to ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Tonight’s Hot Topic Tuesday revisits injectable weight-loss drugs and the new discoveries coming out about the medications.

We can't have it both ways. If we want more cutting-edge drugs, we have to protect the property rights that make them ...